Esperion "announced that it has entered into a definitive agreement with healthcare-focused institutional investors for the issuance and sale of an aggregate of 33,170,747 shares of its common stock and short-term warrants to purchase up to an aggregate of 33,170,747 shares of common stock in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock is being sold together with one short-term warrant to purchase one share of common stock at a combined purchase price of $1.675. The short-term warrants will be immediately exercisable upon issuance, will expire three and a half years following the issuance date and have an exercise price of $1.55 per share. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ESPR:
- Biotech Alert: Searches spiking for these stocks today
- Esperion downgraded to Underperform at Northland amid milestone uncertainty
- Esperion downgraded to Underperform from Market Perform at Northland
- Esperion price target lowered to $12 from $16 at Needham
- Esperion Tanks after Dispute with Daiichi Sankyo